![]() |
|
|
Vol. 10, Issue 6, 1811-1820, June 1999
Molecular Biology and Virology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037
Submitted November 30, 1998; Accepted April 5, 1999| |
ABSTRACT |
|---|
|
|
|---|
Dephosphorylation of the natriuretic peptide receptor-A (NPR-A) is
hypothesized to mediate its desensitization in response to atrial
natriuretic peptide (ANP) binding. Recently, we identified six
phosphorylation sites within the kinase homology domain of NPR-A and
determined that the conversion of these residues to alanine abolished
the ability of the receptor to be phosphorylated or to be activated by
ANP and ATP. In an attempt to generate a form of NPR-A that mimics a
fully phosphorylated receptor but that is resistant to
dephosphorylation, we engineered a receptor variant (NPR-A-6E)
containing glutamate substitutions at all six phosphorylation sites.
Consistent with the known ability of negatively charged glutamate
residues to substitute functionally, in some cases, for phosphorylated
residues, we found that NPR-A-6E was activated 10-fold by ANP and ATP.
As determined by guanylyl cyclase assays, the hormone-stimulated
activity of the wild-type receptor declined over time in membrane
preparations in vitro, and this loss was blocked by the
serine/threonine protein phosphatase inhibitor microcystin. In
contrast, the activity of NPR-A-6E was more linear with time and was
unaffected by microcystin. The nonhydrolyzable ATP analogue adenosine
5'-(
,
-imino)-triphosphate was half as effective as ATP
in stimulating the wild-type receptor but was equally as potent in
stimulating NPR-A-6E, suggesting that ATP is required to keep the
wild-type but not 6E variant phosphorylated. Finally, the
desensitization of NPR-A-6E in whole cells was markedly blunted
compared with that of the wild-type receptor, consistent with its
inability to shed the negative charge from its kinase homology
domain via dephosphorylation. These data provide the first
direct test of the requirement for dephosphorylation in guanylyl
cyclase desensitization and they indicate that it is an essential
component of this process.
| |
INTRODUCTION |
|---|
|
|
|---|
Cell surface guanylyl cyclase receptors are conserved in organisms
as varied as worms (Yu et al., 1997
), sea urchins (Thorpe and Garbers, 1989
), eels (Katafuchi et al., 1994
), flies
(Liu et al., 1995
), rats (Chinkers et al., 1989
),
and humans (Lowe et al., 1989
). The basic topology of these
receptors is maintained in all species. It consists of an extracellular
ligand-binding domain, a single membrane-spanning region, a
juxtamembrane regulatory region called the kinase homology domain
(KHD), and a carboxyl-terminal guanylyl cyclase catalytic domain
(Garbers and Lowe, 1994
). The activation of these receptors is achieved
by the binding of a unique peptide ligand to their extracellular
domains. The quintessential example of this receptor class is the
mammalian natriuretic peptide receptor-A (NPR-A), which is also known
as guanylyl cyclase-A (GC-A) (Chinkers and Garbers, 1989
; Lowe et
al., 1989
). One activator of NPR-A is atrial natriuretic peptide
(ANP), a cardiac hormone that regulates vascular smooth muscle tone,
renal fluid balance, and cell proliferation (Ruskoaho, 1992
; Drewett
and Garbers, 1994
). In intact cells and crude membrane preparations,
the addition of ANP results in the rapid production of cGMP.
However, after an initial burst, the guanylyl cyclase activity of the
enzyme is attenuated with a t1/2 of ~30 min (Woods
and Houslay, 1991
; Yasunari et al., 1992
). This process is
known as homologous desensitization and is characterized by the waning
of enzymatic activity in the continuing presence of hormone (Sibley and
Lefkowitz, 1985
).
A similar desensitization response has been observed with various sea
urchin guanylyl cyclase receptors (Ward et al., 1986
; Garbers, 1989
). In this system, the most active form of the enzyme has
been correlated with a slower migrating form of the cyclase on
SDS-PAGE. The addition of its activating peptide results in a very
rapid initial burst of enzymatic activity followed by a subsequent
equally rapid decline in activity (Bentley et al., 1986
).
The activity reductions have been shown to be coincident with an
increase in the electrophoretic mobility of the cyclase, and this
increase was shown to result from receptor dephosphorylation with the
stoichiometry of phosphorylation decreasing from 15-17 mol of
phosphate/mol of receptor in the absence of egg peptide to 2 mol of
phosphate/mol of receptor in the presence of the peptide (Vacquier and
Moy, 1986
; Ramarao and Garbers, 1988
). Similarly, NPR-A and the closely
related NPR-B have been shown to be constitutively phosphorylated when
isolated from transfected tissue culture cells (Potter and Garbers,
1992
, 1994
; Potter, 1998
; Koller et al., 1993
). Exposure of
these receptors to the appropriate natriuretic peptides results in
their desensitization, and the reduced activity correlates with
receptor dephosphorylation (Potter and Garbers, 1992
; Potter, 1998
).
Furthermore, the treatment of NPRs either in crude membranes (Potter
and Garbers, 1992
; Potter, 1998
) or highly purified preparations of sea
urchin cyclase (Ramarao and Garbers, 1988
) with protein phosphatase
(PP) results in both receptor dephosphorylation and desensitization.
More recently, Foster and Garbers (1998)
showed that NPR-A could be
desensitized and then resensitized in crude membranes if adenosine
5'-O-(thiotriphosphate) was included in the
preparations. They also demonstrated that a serine/threonine PP
inhibitor, microcystin, could block the in vitro desensitization
(Foster and Garbers, 1998
). The target of the phosphatase was not
identified, but the phosphorylation state of NPR-A was shown to be
modulated by the phosphatase inhibitor, which is consistent with the
idea of NPR-A being desensitized by a microcystin-sensitive PP. They
concluded that ATP increased the activity of NPR-A in vitro by
allosterically activating it but also by serving as a substrate for a
protein kinase. Hence, adenosine 5'-O-(thiotriphosphate) is
a better activator than ATP, because thiophosphorylated proteins are
more resistant to dephosphorylation.
Based on these and other data, it has been proposed that receptor
guanylyl cyclase desensitization is mediated by dephosphorylation. To
test this hypothesis, we identified six major phosphorylation sites
located within the KHD of NPR-A (Potter and Hunter, 1998b
). The
mutation of any single site to alanine resulted in decreased ANP-dependent cyclase activity, and the conservative replacement of
four or more of these sites with alanine yielded a receptor mutant that
was completely unresponsive to ANP. Recently, we showed that the
removal of the major NPR-B phosphorylation sites also results in a
dramatic reduction in its hormone-dependent activity (Potter and
Hunter, 1998a
).
The alanine mutants of NPR-A and NPR-B were instructive regarding the
requirement for phosphorylation in the activation of these receptors,
but they could not be used to test whether dephosphorylation is
required for homologous desensitization response because they are
completely unresponsive to hormone. Indeed, these mutants appear to
represent the completely desensitized forms of NPR-A and -B. In an
attempt to generate an NPR-A mutant that would mimic the phosphorylated
state but could not be dephosphorylated, we tested whether glutamate
substitutions at the known NPR-A phosphorylation sites would yield a
hormonally responsive enzyme, because in some cases acidic amino acid
substitutions for serines and threonines have been shown to substitute
functionally for phosphorylated versions of these residues (Thorsness
and Koshland, 1987
; Yan and Templeton, 1994
). We found that the
conversion of all six sites to glutamate yielded a receptor variant
(NPR-A-6E) that was not phosphorylated but was activated almost 10-fold
by ANP. Using this constitutively "phosphorylated" hormonally
responsive receptor, we were then able to test directly the
"desensitization by dephosphorylation" hypothesis. We observed that
the desensitization of the phosphate-negative NPR-A mutant both in
vitro and in whole cells was markedly diminished compared with the
wild-type receptor.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Vector Construction
The phosphorylation site mutations were generated on the
~700-bp BamHI-XbaI fragment of NPR-A, which
was subcloned into pBluescript II (Stratagene, San Diego, CA). The
mutations were generated using the Quikchange kit from Stratagene
according to the manufacturer's protocols. The mutant
BamHI-XbaI fragments were then subcloned back
into the corresponding region of the expression plasmid pCMV3-GC-A (Potter and Garbers, 1992
). All indicated mutations and the absence of
unwanted mutations were confirmed by manual or automated nucleic acid sequencing.
Cell Culture and Transient Transfections
The 293 cell line stably expressing NPR-A (293-GC-A) and the 293 cells used for transient transfections (293neo) have been previously
described (Potter and Garbers, 1992
). Neither cell line endogenously
expresses NPR-A or NPR-B based on natriuretic peptide-dependent cGMP
elevations in whole cells (Potter and Garbers, 1992
). For
transfections, the cells were grown to 40-50% confluence in 10-cm
dishes that had been precoated with a 50 µg/ml solution of
poly-L-lysine. Twenty-four hours later, the cells
were transfected with 5 µg of the various pCMV3-NPR-A constructs
using the BES-buffered calcium phosphate coprecipitation method.
Forty-eight to 72 h later, the cells were harvested for membrane
preparation. Transfections with a cytomegalovirus (CMV)-driven green
fluorescent protein reporter plasmid indicated that the transfection
efficiency was between 30 and 60%.
Whole-Cell Cyclic GMP Elevations
Twenty-four hours after transfections, the cells were split into 12-well dishes and incubated overnight. The next day these cells were ~50-75% confluent and were washed once with 1 ml of Dulbecco's modified Eagle's medium (DMEM). The plates were then moved to ambient temperature and incubated with 0.5 ml of DMEM containing 0.5 mM 1-methyl-3-isobutylxanthine (a phosphodiesterase inhibitor used to block cGMP degradation) and 200 µM ANP for various periods. cGMP production was terminated by adding 0.5 ml of 6% trichloroacetic acid to each well at the appropriate time. The amount of cGMP contained in each well (cells and medium) was determined using a cGMP radioimmunoassay kit from DuPont NEN (Boston, MA) according to the manufacturer's protocol.
Membrane Preparation
Ten-centimeter plates of transiently or stably transfected 293 cells were washed once with 10 ml of PBS and then scraped off the plate
in 0.5 ml of phosphatase inhibitor buffer [50 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.4, 20%
glycerol, 50 mM NaCl, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 1 µg/ml pepstatin, 10 mM NaPO4, pH 7.0, 0.1 M NaF, 1 mM
Na3VO4, 80 µM
-glycerol phosphate, and 0.1 µM okadaic acid), sonicated with a Branson (Plainview, NY) Sonifier
cell disrupter at 4°C, and centrifuged at 15,800 × g
for 20 min at 2°C. The resulting membrane pellet was resuspended in
HGPB [50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH
7.4, 10% glycerol, 50 mM NaCl, 10 µg/ml leupeptin, 10 µg/ml
aprotinin, and 1 µg/ml pepstatin] at a protein concentration of
between 1.0 and 2.5 mg/ml as estimated by the BCA protein assay
(Pierce, Rockford, IL). For experiments in which we did not wish to
preserve the phosphorylation state of NPR-A (see Figures 4 and 5), we
lysed the cells in HGPB with no phosphatase inhibitors.
Immunoblot Analysis
Crude membranes containing NPR-A were separated by SDS-PAGE and
electroblotted onto an Immobilon-P membrane (Millipore, Bedford, MA) as previously described (Potter and Hunter, 1998b
). The
membrane was then blocked for 1 h in TBST (20 mM Tris, 500 mM
NaCl, and 0.05% polyoxyethylene sorbitan monolaurate, pH 7.5)
containing 3% BSA, washed three times for 5 min with TBST, and then
incubated with rabbit polyclonal antiserum R1215 (Potter and Garbers,
1992
) diluted 1:200 in TBST containing 1% BSA for 2 h at 25°C.
The membrane was washed three times for 10 min with TBST and incubated
for 45 min at 25°C with an affinity-purified 125I-coupled
donkey anti-rabbit-directed secondary antibody. The membrane was then
washed once for 15 min and twice for 5 min in TBST. The NPR-A-antibody
complex was visualized by autoradiography, and then the corresponding
bands were cut out of the membrane and quantitated in a
counter.
Guanylyl Cyclase Assays
All guanylyl cyclase assays were conducted at 37°C in the
presence of 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid,
pH 7.4, 50 mM NaCl, 0.25 mM 1-methyl-3-isobutylxanthine, 0.1% BSA, 5 mM creatine phosphate, 5-10 U/assay creatine phosphokinase, 1 mM GTP,
and 0.1-0.2 µCi of [
-32P]GTP. Five millimolar
MgCl2, 1 mM ATP, and 1 µM ANP or 1% Triton X-100 and 3 mM MnCl2 were also included in the reaction mixtures. Basal
activity levels were determined in the presence of only 5 mM
MgCl2. Assays were initiated by the addition of a solution of the above reagents to crude membranes in a total volume of 0.1 ml.
The experiment described in Figure 5 was initiated by the addition of
680 µl of prewarmed reaction mixture to 120 µl of crude membranes.
The reactions were terminated at the appropriate time points by
transferring 100-µl aliquots to 0.5 ml of 110 mM zinc acetate on ice.
cGMP accumulation was quantitated as described by Domino et
al. (1991)
.
| |
RESULTS |
|---|
|
|
|---|
NPR-A Desensitization Is Biphasic
When 293 cells stably expressing NPR-A (Potter and Garbers, 1992
)
were incubated with ANP for increasing periods, hormone-dependent guanylyl cyclase activity assayed in crude membranes derived from these
cells declined in a biphasic manner (Figure
1, filled circles). Within the first 30 min after ANP addition to the medium, hormone-dependent activity
dropped to ~50% of the original level (Figure 1A). This decrease has
been shown to be tightly correlated with receptor dephosphorylation
(Potter and Garbers, 1992
). After the initial acute phase, the rate of
decline subsided, and the loss of activity correlated with decreases in
ANP-independent activity, as indicated by guanylyl cyclase activity
determinations in the presence of detergent (Figure 1, open circles)
and in the amount of NPR-A immunoreactivity detected in membrane
preparations (Figure 1, triangles). Both of these measurements are
indicators of the total amount of NPR-A protein present in the membrane
preparations. The transient nature of the acute desensitization
response is revealed by plotting the ratio of the two guanylyl cyclase
determinations (ANP-dependent activity/detergent-dependent activity)
versus the time of ANP incubation (Figure 1B). This graph indicates
that the rapid response is essentially complete after 30 min and
suggests that the additional decreases in hormone-dependent activity
observed with longer incubations are due to receptor degradation. Thus, it appears that dephosphorylation and down-regulation acutely and
chronically regulate NPR-A, respectively.
|
Substitution of the Phosphorylated Residues with Glutamate Yields Hormonally Responsive Receptors
Because the conversion of four or more of the phosphorylated
residues within NPR-A to alanine resulted in a hormonally insensitive (i.e., fully desensitized) enzymes, we were unable to test the effect
of removing these sites on the desensitization process (Potter and
Hunter, 1998b
). However, because we were able to functionally substitute a glutamate residue for serine-497 in NPR-A (Potter and
Hunter, 1998b
), we asked whether the conversion of the remaining phosphorylatable residues to glutamate might result in a receptor lacking phosphate but still hormonally responsive. To this end, we
constructed two glutamate-substituted NPR-A mutants (Figure 2). The first one (5E) was made before we
had determined that threonine 513 was phosphorylated, and it contains
glutamate substitutions at all of the known NPR-A phosphorylation sites
except Thr-513. The second one (6E) is identical to the first, except
Thr-513 is also converted to glutamate. Neither the 5E nor the 6E
mutant is detectably phosphorylated when isolated from
32P-labeled cells.
|
We compared the activities of the 5E and 6E mutants to the wild-type
NPR-A and the 5A mutant, which contains alanine substitutions at the
first five KHD NPR-A phosphorylation sites and which is completely
unresponsive to ANP (Potter and Hunter, 1998b
). When basal measurements
were determined in the absence of ANP and ATP (Mg2+-GTP
only), the guanylyl cyclase activities of the glutamate (5E and 6E)
mutants were similar to those obtained for the 5A and wild-type
receptors (Figure 3A). However, because
these activities were not significantly higher than those obtained from
vector alone-transfected cells, we could not be sure that the
expression level of each mutant protein was similar. Therefore, we
repeated the assay in the presence of Triton X-100 and
Mg2+-GTP (Figure 3B). These conditions artificially
stimulate NPR-A to maximum levels in an ANP-independent manner (Potter
and Garbers, 1992
). Again, we found that the activities of the mutant
receptors were relatively similar. We next tested whether the
glutamate-substituted receptors were responsive to physiological
activation by assaying in the presence of ANP, ATP, and
Mg2+-GTP. Under these conditions, the 5E and 6E mutant
receptors were activated 7- and 10-fold over their corresponding basal
levels, respectively (Figure 3A). In contrast, the 5A mutant was
completely insensitive to ANP activation. Based on these observations,
it appears that one major function of these phosphorylation sites is to
provide a region of localized negative charge within the KHD that is
required for ANP responsiveness. However, it should be noted that under
the same conditions the wild-type receptor was stimulated almost
14-fold over its respective basal level (Figure 3A), and its activation
ratio is markedly higher than those of the 5E or 6E receptors (Figure
3C). Hence, the glutamate substitutions should not be considered
completely equivalent to the phosphorylated wild-type residues.
|
Equivalent Activation of NPR-A-6E by Adenine Nucleotides
Recently it was reported that ATP serves a dual role in the
activation of NPR-A (Foster and Garbers, 1998
). It was suggested that
ATP is both an allosteric regulator of NPR-A as well as a substrate in
a protein kinase reaction. The substrate of the kinase reaction was not
determined, but microcystin was shown to increase the 32P
content of NPR-A when [
-32P]ATP was included in
guanylyl cyclase assays. To assess whether the phosphorylation of the
KHD of NPR-A is sufficient to mediate the differing effects of various
adenine nucleotides, we tested the effect of ATP and the
nonhydrolyzable analogue adenosine
5'-(
,
-imino)triphosphate (AMPPNP) on the activation of
NPR-A and NPR-A-6E in the presence of saturating concentrations (1 µM) of ANP. We reasoned that if NPR-A is the target of this
phosphorylation reaction, then ATP and AMPPNP should be equivalent
activators of NPR-A-6E, because this receptor is unable to be
phosphorylated. We observed that the wild-type receptor was activated
3.6-fold with AMPPNP, and this activation was almost doubled by the
addition of microcystin (Figure 4). ATP
alone activated the wild-type receptor 6.7-fold, and microcystin
increased the activation to 8.4-fold. In contrast, AMPPNP was as
efficacious as ATP in activating NPR-A-6E (~7 fold), and the
inclusion of microcystin had no additional effect on NPR-A-6E activity
assayed in the presence of either ATP or AMPPNP. These data suggest
that the KHD of NPR-A is a target for a protein kinase that is present
in these membrane preparations, and that the ability of ATP, but not
AMPPNP, to serve as a substrate in the phosphorylation of NPR-A is
sufficient to account for their differing potencies.
|
NPR-A-6E Is Resistant to Desensitization and Microcystin In Vitro
We next asked whether NPR-A-6E was resistant to desensitization in
guanylyl cyclase assays. Because it has recently been shown that
microcystin, a known inhibitor of PP1, PP2A, PP4, and PP5, can preserve
the ANP- and ATP-dependent activity of NPR-A in guanylyl cyclase assays
conducted in crude membranes (Foster and Garbers, 1998
), we asked
whether this PP inhibitor was preventing the dephosphorylation of NPR-A
or some other protein. We reasoned that if NPR-A were the target
molecule, then NPR-A-6E should be unaffected by microcystin, because it
cannot be dephosphorylated. When we measured the hormone-dependent guanylyl cyclase activity of wild-type NPR-A in membranes, we found
that product formation was almost linear for the first 5 min but began
to fall off thereafter (Figure 5). As
previously reported (Foster and Garbers, 1998
), the inclusion of
microcystin in the assay blocked this loss of activity, although the
block is not as complete in these cells as was demonstrated for NPR-A expressed in NIH3T3 cells. In contrast to wild-type NPR-A, microcystin had absolutely no effect on the ANP-stimulated activity of NPR-A-6E, which was lower than that of the ANP-stimulated wild-type receptor (Figure 5). These data indicate that NPR-A is the target of the microcystin-sensitive phosphatase.
|
NPR-A-6E Displays a Blunted Whole-Cell Desensitization Response
With the construction of NPR-A-6E, we were now able to test
directly the role of dephosphorylation in the whole cell
desensitization process. To this end, we repeated the experiment
described in Figure 1 by transiently transfecting the same parental 293 cell line with the NPR-A-6E construct. As can be seen by comparing Figures 1A and 6A, losses in subsequent
hormone-dependent guanylyl cyclase activities of the 6E mutant were
markedly diminished compared with the wild-type receptor. Likewise, the
ANP-dependent reductions in the activity ratio of the 6E variant were
also reduced in comparison with the wild-type receptor (compare Figures
1B and 6B). The diminished desensitization response of the 6E variant
was not a function of the transient transfection procedure or
experiment-to-experiment variation, because a 4-h ANP treatment reduced
the activity of the wild-type receptor to 38% of its untreated value,
whereas the identical treatment of the 6E receptor (performed in the
same experiment) only reduced its activity to 83% (Figure 4A).
Additionally, the activity ratio of the 6E variant was reduced to only
80% compared with 50% for the wild-type receptor in the transiently
transfected 293 cells (Figure 4B). Thus, by blocking the ability of
NPR-A to shed its negative charge via dephosphorylation, we were able to block ~60% of the desensitization response in these cells.
|
To confirm the results obtained by guanylyl cyclase assays, we asked
whether the ANP-dependent cGMP accumulations in whole cells transfected
with the 6E mutant receptor were more linear than those observed in
cells transfected with the wild-type receptor. We found that cells
expressing the wild-type receptor accumulate cGMP very rapidly
initially, but after a few minutes the rate of accumulation declines
(Figure 7). Cells expressing the 6E
mutant had decreased ANP-dependent cGMP accumulation compared with
cells expressing the wild-type receptor, which is consistent with the diminished ANP-dependent guanylyl cyclase activity of NPR-A-6E (Figure
3). However, in contrast to the cells expressing the wild-type receptor, the rate of cGMP accumulation in these cells only declined slightly over the course of 1 h (Figure 7). These data indicate that NPR-A undergoes homologous desensitization in whole cells, and
that this desensitization is mediated, at least in part, by dephosphorylation of the sites in the KHD.
|
Mutation of Ser-497 or Thr-500 Alone Does Not Block Desensitization
Finally, we asked whether the dephosphorylation of a single
residue was sufficient to cause desensitization or whether the desensitization was mediated by a coordinated dephosphorylation of all
six residues. The homologous but not heterologous desensitization of
both NPR-A and B has been suggested to be mediated by the simultaneous dephosphorylation of all the receptor phosphorylation sites, because tryptic phosphopeptide maps of the desensitized receptors are identical
to those of the wild-type receptors, even though they contain markedly
less phosphate (Potter and Garbers, 1992
; Potter, 1998
). Because the
mutation of serine 497 to alanine (S497A) results in the most dramatic
decrease in hormone-dependent guanylyl cyclase activity of NPR-A, and
because we were able to restore activity by mutating this residue to
glutamate (S497E), we asked whether either of these mutations would
block the desensitization of NPR-A. We tested the ability of a receptor
containing an alanine in place of threonine 500 (T500A) and the 5E
mutant as well. We found that the incubation of cells expressing the
wild-type receptor with 200 nM ANP for 1 h resulted in membranes
that contained reduced hormone-dependent guanylyl cyclase activity
(Figure 8). However, the S497A, S487E,
and T500A mutants desensitized to equal or greater levels than the
wild-type receptor. In contrast, the 5E receptor displayed a muted
desensitization response. These data are consistent with the notion
that homologous desensitization is mediated by a coordinated
dephosphorylation of all the phosphorylation sites in the NPR-A KHD.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this report, we have described serine and threonine to
glutamate mutations within the KHD of NPR-A, which functionally substitute for the phosphorylated versions of these amino acids in
facilitating hormone responsiveness. These observations are consistent
with our previous data, which suggested that the phosphorylation of
NPR-A is required for ANP-dependent activation (Potter and Hunter,
1998b
). Although not as hormonally responsive as the wild-type receptors, these glutamate-substituted mutants proved to be extremely useful tools because they allowed us to test directly the role of
dephosphorylation in the desensitization of NPR-A. We observed that
desensitization of the NPR-A-6E mutant was markedly diminished compared
with the wild-type receptor both in vitro and in vivo. Taken together,
the data strongly suggest that receptor dephosphorylation is required
for normal desensitization.
Whether the hormone-dependent dephosphorylation of NPR-A is mediated by
the activation of a PP or the inactivation of a protein kinase it not
clear, but the blocking effect of microcystin in the membrane
preparations suggests that it may be the former. The identity of the
responsible PP is not currently known, but our results and those of
Foster and Garbers (1998)
suggest that it is likely to be a
membrane-associated, microcystin- and okadaic acid-sensitive
phosphatase species, which currently include PP1, PP2A, PP4, and PP5.
We have tested the ability of purified preparations of PP1, PP2A, and
PP5, a phosphatase that was recently shown to associate with the KHD of
NPR-A in a two-hybrid screen (Chinkers, 1994
), to dephosphorylate
immunopurified NPR-A bound to protein A-agarose (Cohen and Potter,
unpublished observations). We found that all three phosphatases were
able to dephosphorylate NPR-A but that none of these enzymes was able
to remove all of the phosphate from the receptor, even at relatively
high concentrations. However, we have not tested whether the presence
of ANP and ATP may make NPR-A a better substrate for these
phosphatases. Finally, it is important to note that we have not been
able to block either the homologous or heterologous desensitization of
NPR-A in whole 293 cells with micromolar concentrations of okadaic
acid, which should be sufficient to inhibit PP1, PP2A, PP4, and PP5
completely. The reason for this is not known, but it may be that
the intracellular concentration of okadaic acid is less than is
necessary to inhibit the relevant PP over the period assayed, or else
the physiological PP may be okadaic acid insensitive e.g., PP2B or
PP2C. The discrepancy between the in vitro and in vivo sensitivity also
could be explained if cell lysis allows a nonphysiological
membrane-associated, microcystin-sensitive PP access to NPR-A in the in
vitro assays.
It is important to point out that the initial phase of the desensitization of NPR-A-6E was not completely abolished. This indicates that some other, as yet unidentified, mechanism(s) is involved in this process. The nature of the dephosphorylation-independent process is currently unknown. One possibility is that a specific regulatory protein is required for the activation of this receptor and that this protein is degraded or inactivated in response to ANP. Another possibility is that NPR-A could be internalized in endosomes and multivesicular bodies and therefore be excluded from activators or substrate. Alternatively, it may be that NPR-A or its putative regulatory protein is inhibited in a phosphorylation-independent posttranslational modification process, such as fatty acid acylation or methylation. Finally, we note that in contrast to the wild-type receptor, the detergent-dependent guanylyl cyclase activity of NPR-A-6E (i.e., total receptor level) was not reduced by up to 4 h of ANP exposure (Figure 6A). This suggests that receptor dephosphorylation may also be involved in the down-regulation of NPR-A. The mechanism of down-regulation is not known, but because there is a corresponding decrease in receptor protein levels, it presumably results from degradation. Whether internalization, degradation, or both processes are affected by dephosphorylation is currently not known.
There are many similarities between the structure and regulation of
mammalian natriuretic peptide and sea urchin egg peptide guanylyl
cyclase receptors (Chinkers and Garbers, 1991
). This is particularly
apparent regarding their common mechanism of desensitization. Recently,
Furuya et al. (1998)
used mass spectrometric analysis to
identify 14 of a predicted 26 phosphorylation sites within the H. pulcherrimus sea urchin guanylyl cyclase. Unlike NPR-A and
-B, this sea urchin cyclase contained several sites (894, 918, 927, and
930) located within the guanylyl cyclase catalytic domain. However, two
of the identified sites (561 and 565) are located in the same general
region as the N-terminal sites found in NPR-A and NPR-B. What role, if
any, these sites play in the regulation of the egg peptide-sensitive
guanylyl cyclase activity of this receptor has not been reported.
In conclusion, cell surface guanylyl cyclases are, to our knowledge,
the only receptors that are desensitized by dephosphorylation. This
mechanism is the complete opposite of that used by G-protein-coupled receptors, which are attenuated by direct receptor phosphorylation. These serpentine receptors have evolved a highly specialized network of
proteins that are required for this process, including specific G-protein receptor kinases, phosphatases, and molecules known as
arrestins that associate with specific receptors in a
phosphorylation-dependent manner (Krupnick and Benovic, 1998
). Whether
a family of regulatory proteins has specifically evolved to regulate
guanylyl cyclase receptors or whether these receptors use more general
cellular machinery for these purposes remains to be determined.
However, it is now clear that protein kinases and phosphatases are
crucial regulators of some members of this expanding family of enzymes.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by US Public Health Service grants CA-14195 and CA-39780 (to T.H.). L.R.P. was supported by National Research Service Award CA-67452 from the National Institutes of Health. T.H. is a Frank and Else Schilling American Cancer Society Research Professor.
| |
FOOTNOTES |
|---|
* Corresponding author. E-mail address: potter{at}salk.edu.
| |
ABBREVIATIONS |
|---|
Abbreviations used:
AMPPNP, adenosine
5'-(
,
-imino)triphosphate;
ANP, atrial natriuretic peptide;
CMV, cytomegalovirus;
CNP, C-type natriuretic peptide;
DMEM, Dulbecco's
modified Eagle's medium;
GC-A, guanylyl cyclase-A;
KHD, kinase
homology domain;
NPR-A, natriuretic peptide receptor A;
NPR-B, natriuretic peptide receptor B;
PP, protein phosphatase.
| |
REFERENCES |
|---|
|
|
|---|
-adrenergic receptor-coupled adenylate cyclase system as a model.
Nature
317, 124-129[Medline].This article has been cited by other articles:
![]() |
G. Bereta, B. Wang, P. D. Kiser, W. Baehr, G.-F. Jang, and K. Palczewski A Functional Kinase Homology Domain Is Essential for the Activity of Photoreceptor Guanylate Cyclase 1 J. Biol. Chem., January 15, 2010; 285(3): 1899 - 1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Antos and L. R. Potter Adenine nucleotides decrease the apparent Km of endogenous natriuretic peptide receptors for GTP Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1756 - E1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Potter, S. Abbey-Hosch, and D. M. Dickey Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions Endocr. Rev., February 1, 2006; 27(1): 47 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fan, P. M. Bryan, L. K. Antos, R. J. Potthast, and L. R. Potter Down-Regulation Does Not Mediate Natriuretic Peptide-Dependent Desensitization of Natriuretic Peptide Receptor (NPR)-A or NPR-B: Guanylyl Cyclase-Linked Natriuretic Peptide Receptors Do Not Internalize Mol. Pharmacol., January 1, 2005; 67(1): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Airhart, Y.-F. Yang, C. T. Roberts Jr., and M. Silberbach Atrial Natriuretic Peptide Induces Natriuretic Peptide Receptor-cGMP-dependent Protein Kinase Interaction J. Biol. Chem., October 3, 2003; 278(40): 38693 - 38698. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Abbey and L. R. Potter Vasopressin-dependent Inhibition of the C-type Natriuretic Peptide Receptor, NPR-B/GC-B, Requires Elevated Intracellular Calcium Concentrations J. Biol. Chem., November 1, 2002; 277(45): 42423 - 42430. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Bryan and L. R. Potter The Atrial Natriuretic Peptide Receptor (NPR-A/GC-A) Is Dephosphorylated by Distinct Microcystin-sensitive and Magnesium-dependent Protein Phosphatases J. Biol. Chem., May 3, 2002; 277(18): 16041 - 16047. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Muller, R. Middendorff, J. Olcese, and A. K. Mukhopadhyay Central Nervous System-Specific Glycosylation of the Type A Natriuretic Peptide Receptor Endocrinology, January 1, 2002; 143(1): 23 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Hussain, R. J. MacAllister, and A. J. Hobbs Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1151 - H1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Gukovskaya, S. Gukovsky, and S. J. Pandol Endoplasmic reticulum Ca2+-ATPase inhibitors stimulate membrane guanylate cyclase in pancreatic acinar cells Am J Physiol Cell Physiol, February 1, 2000; 278(2): C363 - C371. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Potter and T. Hunter Activation of Protein Kinase C Stimulates the Dephosphorylation of Natriuretic Peptide Receptor-B at a Single Serine Residue. A POSSIBLE MECHANISM OF HETEROLOGOUS DESENSITIZATION J. Biol. Chem., September 29, 2000; 275(40): 31099 - 31106. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Potter and T. Hunter Guanylyl Cyclase-linked Natriuretic Peptide Receptors: Structure and Regulation J. Biol. Chem., February 23, 2001; 276(9): 6057 - 6060. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||